Related Experiment Videos
Stem cells and the microenvironment in aplastic anaemia
1Leukaemia Research Fund Centre, Institute of Cancer Research, London.
British Journal of Haematology
|January 1, 1994
Summary
Normal blast colony-forming cells bind to stroma with methylprednisolone. Aplastic marrow shows variable BI-CFC and CFU-GM, suggesting the bone marrow microenvironment supports hematopoietic function during failure.
Area of Science:
- Hematology
- Stem Cell Biology
- Bone Marrow Microenvironment
Background:
- Normal blast colony-forming cells (BI-CFC) exhibit specific binding to stroma.
- Methylprednisolone (MP) influences BI-CFC binding and fat cell formation in bone marrow stroma.
- Aplastic anemia is characterized by variable BI-CFC incidence and inconsistent correlation with granulocyte-macrophage colony-forming cell (CFU-GM) levels.
Purpose of the Study:
- To investigate the role of methylprednisolone in BI-CFC binding to bone marrow stroma.
- To evaluate the functional capacity of stroma from aplastic marrow patients.
- To understand the bone marrow microenvironment's response to hematopoietic failure in aplastic anemia.
Main Methods:
- Culturing normal and aplastic bone marrow stroma with and without methylprednisolone (MP).
- Assessing blast colony-forming cell (BI-CFC) binding to cultured stroma.
- Evaluating granulocyte-macrophage colony-forming cell (CFU-GM) content.
- Observing spontaneous fat cell formation in cultured stroma.
Main Results:
- Normal stroma require MP for BI-CFC binding and fat cell formation.
- Stroma from 4/9 aplastic patients spontaneously formed fat cells and bound BI-CFC.
- Stroma from 5/9 aplastic patients, which did not form fat cells spontaneously, still bound BI-CFC better than normal stroma.
- Aplastic marrow shows variable BI-CFC incidence, unrelated to CFU-GM content.
Conclusions:
- The bone marrow microenvironment in aplastic anemia may adapt to bone marrow failure.
- Aplastic marrow stroma can exhibit enhanced BI-CFC binding and support capacity.
- These findings suggest a physiological response of the hematopoietic microenvironment to aplastic anemia.